-
公开(公告)号:EP2437772B1
公开(公告)日:2017-12-06
申请号:EP10784168.6
申请日:2010-06-04
申请人: 13Therapeutics, Inc.
IPC分类号: A61K38/16 , A61K38/02 , A61K38/10 , C07K14/00 , C07K7/08 , A61P29/00 , A61P17/06 , A61P17/00 , A61P19/02
CPC分类号: A61K39/285 , A61K38/00 , C07K7/06 , C07K7/08 , C07K14/005 , C07K14/07 , C07K14/47 , C07K2319/10 , C12N2710/24122
摘要: Peptides for the treatment of inflammation, and therapeutic uses and methods of using the same are disclosed. Peptides including a transducing sequence are effective for inhibiting cytokine activity and TNF-alpha secretion through interaction with toll-like receptors. Experiments are described illustrating the efficacy of the compounds in treating otitis media.
-
公开(公告)号:EP2437772A4
公开(公告)日:2013-07-10
申请号:EP10784168
申请日:2010-06-04
申请人: 13THERAPEUTICS INC
IPC分类号: A61K38/16 , A61K38/02 , A61K38/10 , A61P17/00 , A61P17/06 , A61P19/02 , A61P29/00 , C07K7/08 , C07K14/00
CPC分类号: A61K39/285 , A61K38/00 , C07K7/06 , C07K7/08 , C07K14/005 , C07K14/07 , C07K14/47 , C07K2319/10 , C12N2710/24122
摘要: Peptides for the treatment of inflammation, and therapeutic uses and methods of using the same are disclosed. Peptides including a transducing sequence are effective for inhibiting cytokine activity and TNF-alpha secretion through interaction with toll-like receptors. Experiments are described illustrating the efficacy of the compounds in treating otitis media.
-
公开(公告)号:EP2437772A1
公开(公告)日:2012-04-11
申请号:EP10784168.6
申请日:2010-06-04
申请人: 13therapeutics, Inc.
IPC分类号: A61K38/16 , A61K38/02 , A61K38/10 , C07K14/00 , C07K7/08 , A61P29/00 , A61P17/06 , A61P17/00 , A61P19/02
CPC分类号: A61K39/285 , A61K38/00 , C07K7/06 , C07K7/08 , C07K14/005 , C07K14/07 , C07K14/47 , C07K2319/10 , C12N2710/24122
摘要: Peptides for the treatment of inflammation, and therapeutic uses and methods of using the same are disclosed. Peptides including a transducing sequence are effective for inhibiting cytokine activity and TNF-alpha secretion through interaction with toll-like receptors. Experiments are described illustrating the efficacy of the compounds in treating otitis media.
-
-